Philadelphia Pharmaceuticals Company (ASE:PHIL)
1.590
0.00 (0.00%)
At close: May 10, 2026
16.06% (1Y)
| Market Cap | 12.08M +15.8% |
| Revenue (ttm) | 9.00M +1.9% |
| Net Income | 1.04M +21.4% |
| EPS | 0.14 +21.4% |
| Shares Out | 7.50M |
| PE Ratio | 11.67 |
| Forward PE | n/a |
| Dividend | 0.07 (4.40%) |
| Ex-Dividend Date | Mar 30, 2026 |
| Volume | 1,713 |
| Average Volume | 398 |
| Open | 1.550 |
| Previous Close | n/a |
| Day's Range | 1.550 - 1.600 |
| 52-Week Range | 1.360 - 1.700 |
| Beta | -0.02 |
| RSI | 51.95 |
| Earnings Date | Jul 28, 2026 |